logo
Sign In
Farxiga vs. GlyxambiBerinert vs. CinryzeEmgality vs. QuliptaFarxiga vs. InvokanaFirazyr vs. SajazirGlyxambi vs. InvokanaInvokamet vs. SynjardyOpzelura vs. DupixentOrencia vs. RinvoqQulipta vs. VyeptiStelara vs. TremfyaSynjardy vs. VictozaTaltz vs. BimzelxVyepti vs. Nurtec ODTView all Comparisons
ADHD drugsAnxiety drugsAsthma drugsAtopic dermatitis drugsDepression drugsHeart failure drugsHypertension drugsLymphoma drugsOsteoarthritis drugsRheumatoid arthritis drugsRosacea drugsSchizophrenia drugsType 2 Diabetes drugsView all Indications
Bayer drugsAbbVie drugsAstraZeneca drugsEli Lilly and Company drugsGenetech drugsGlaxoSmithKline (GSK) drugsNovartis drugsPfizer drugsTakeda Pharmaceuticals drugsTeva Pharmaceuticals drugsAmgen drugsView all Manufacturers
Beta-Adrenergic BlockerAngiotensin Converting Enzyme InhibitorAngiotensin 2 Receptor BlockerCalcium Channel BlockerDiureticsHMG-CoA Reductase InhibitorProton Pump InhibitorSelective Serotonin Reuptake InhibitorNorepinephrine Reuptake InhibitorBenzodiazepinesOpioid AgonistsNonsteroidal Anti-inflammatory DrugsAntiepileptic AgentsAntipsychoticsAntihistaminesView all Classes
Wegovy®Ozempic®Mounjaro®Zepbound®Jardiance®Farxiga®Dupixent®Trulicity®Lyrica®Lipitor®Effexor®Concerta®Depakote®Trintellix®Rexulti®Rinvoq®Verzenio®Taltz®
For ProvidersRequest DemoJoin Research Panel
For BusinessHCP ChannelCommercial O/SEngageMarketplaceOneHubInsight
Tools & MorePrescribing InfoCoverageSavingsPatient ResourcesA-Z IndicationsCompare Drugs
CompanyAboutInsightsCareersContactSecurity
Legit Script Certified
Get the latest insights in your inbox
Follow us
Legit Script Certified
  • Terms and Conditions
  • Privacy Policy
  • © 2025 PrescriberPoint. All Rights Reserved.

    • Aluminum Complex class drugs

    FiltersReset Filters
    5 results

    • sucralfate

      (Sucralfate Oral)
      AvPAK
      Usage: Sucralfate Oral Suspension is indicated for the short-term treatment (up to 8 weeks) of active duodenal ulcers.

    • sucralfate

      (Sucralfate Oral)
      AvKARE
      Usage: Sucralfate Oral Suspension is indicated for the short-term treatment (up to 8 weeks) of active duodenal ulcers.

    • sucralfate

      (Sucralfate Oral)
      TruPharma, LLC
      Usage: Sucralfate Oral Suspension is indicated for the short-term treatment (up to 8 weeks) of active duodenal ulcers.

    • sucralfate

      (Sucralfate)
      Pacific Pharma, Inc.
      Usage: Sucralfate Oral Suspension is indicated for the short-term treatment (up to 8 weeks) of active duodenal ulcers.

    • sucralfate

      (Sucralfate)
      Ingenus Pharmaceuticals, LLC
      Usage: Sucralfate Oral Suspension is indicated for the short-term treatment (up to 8 weeks) of active duodenal ulcers.